Monitoring Liver Function during Methotrexate Therapy for Psoriasis
- 1 January 2005
- journal article
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 6 (6) , 357-363
Abstract
Methotrexate is a widely used and efficacious treatment for psoriasis. Current recommendations advise liver biopsy after each cumulative 1–1.5g dosage of methotrexate. Although studies of methotrexate hepatotoxicity in psoriasis are of variable quality, the evidence indicates that in patients with no risk factors for liver disease on long-term, low-dosage (<20mg), once-weekly methotrexate, liver biopsy is justified after an initial cumulative dosage of 4g. Advances in the non-invasive assessment of liver fibrogenesis may eventually further reduce the need for biopsy.Keywords
This publication has 43 references indexed in Scilit:
- The Relationship Of In Vivo 31P Mr Spectroscopy to Histology in Chronic Hepatitis CHepatology, 2003
- Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patientsBritish Journal of Dermatology, 1996
- Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: Relation to liver fibrosis and arthritisJournal of the American Academy of Dermatology, 1991
- Methotrexate in psoriasis: Revised guidelinesJournal of the American Academy of Dermatology, 1988
- Low incidence of hepatotoxicity associated with long-term, low-dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis, and rheumatoid arthritisDigestive Diseases and Sciences, 1985
- Predictive value of HLA antigen for methotrexate-induced liver damage in patients with psoriasisJournal of the American Academy of Dermatology, 1985
- Combined methotrexate-ultraviolet B therapy in the treatment of psoriasisJournal of the American Academy of Dermatology, 1982
- Methotrexate guidelines—revisedJournal of the American Academy of Dermatology, 1982
- Synthesis and biological evaluation of poly-.gamma.-glutamyl derivatives of methotrexateBiochemistry, 1973
- Methotrexate Hepatotoxicity in Psoriasis—Comparison of Different Dose RegimensBMJ, 1972